|
1
|
|
|
2
|
|
|
3
|
- 60% to 93% in performance horses
- 25% to 50% in foals
|
|
4
|
- Telephone Survey conducted in 2003, of 300 performance horse owners
|
|
5
|
- Results in poor body condition
- Can disrupt training
- Can impair performance
- Can cause colic
- Can have severe complications
|
|
6
|
- Gastric outflow
obstruction
- Esophagitis
- Chronic ulceration
- Perforation (rupture)
& peritonitis
|
|
7
|
|
|
8
|
|
|
9
|
- Gastric lining damage occurs when:
- Aggressive (acid, pepsin, bile,
organic acids) factors overpower
- Defenses (bicarbonate, mucus)
of gastric mucosa
- Squamous mucosa lining lacks these defenses
|
|
10
|
- Intensive exercise
- Reduced blood flow to the stomach lining?
- Increased gastric acidity?
- Altered eating behavior?
|
|
11
|
|
|
12
|
- Feeding management
- Low prevalence of ulcers in horses at pasture
|
|
13
|
- Decreased acid when roughage available
- Increased serum gastrin when fed
concentrates (grains & sweet feeds)
- Intermittent feed deprivation =
gastric ulcers
- Stall confinement = gastric ulcers
- Feeding alfalfa hay may help!
|
|
14
|
|
|
15
|
|
|
16
|
- Gastric acidity is high in empty stomach
- Intermittent feed deprivation
- Lesions form in squamous mucosa
- No lesions form in glandular mucosa
- Lesions prevented by ranitidine (Zantac®)
|
|
17
|
- Physical stress
- Illness
- Painful musculoskeletal disorder
- Behavioral stress
- Stall confinement
- Transport
- Unfamiliar environment,
social regrouping
|
|
18
|
- Phenylbutazone & Flunixin Meglumine
and other NSAIDs
- Associated with ulcers throughout the intestinal tract (Cecum &
Colon)
- Inhibit prostaglandins, interrupting
mucosal blood flow
and mucus
- Local toxicity
|
|
19
|
- Poor appetite
- Poor body condition
- Attitude changes
- Decrease in performance
- Mild to moderate colic
|
|
20
|
- Poor appetite or intermittent nursing
- Colic
- Poor body condition
- Frequently lies on back
- Bruxism (grinding of teeth)
- Excessive salivation (Ptylism)
- Diarrhea
|
|
21
|
|
|
22
|
- Clinical signs are suggestive of, but not specific for, EGUS
- Lab: Mild anemia
- Response to treatment can be useful
- Gastric endoscopy is only definitive diagnostic tool
|
|
23
|
- Endoscope quality
& dimensions
- Patient preparation
- Experience
|
|
24
|
|
|
25
|
|
|
26
|
|
|
27
|
|
|
28
|
- Eliminate clinical signs
- Promote healing
- Prevent complications
- Prevent recurrences
|
|
29
|
- Management modifications
- Medical therapy-approaches that have been used
- Control gastric acid
- Mucosal protectants
|
|
30
|
|
|
31
|
- Diet modifications
- Limit periods of fasting
- Increase roughage
- pasture turnout (green grass)
- free choice hay
- Alfalfa hay-dietary antacid
- Reduce grain/concentrates
|
|
32
|
- Fresh Rice Bran and Rice Bran Oil
- Contains surface active phospholipids and cytoprotective factors that
maintain health of the stomach lining
- Rancidity can be a problem
- Produces ketoaldehydes which are ulcerogenic
- Steam pasteurization can help decrease potential for rancidity
- Storage in refrigerator
|
|
33
|
- Limit stressful events
- Long-term stall confinement
- Trailering
- Overcrowding
|
|
34
|
- Acetic, Butyric, Propionic, and Valeric Acids
- Byproducts of carbohydrate fermentation in
the stomach
- Synergistic with HCl
- May lead to non-glandular ulcers
- Increased VFA’s with increased grain
|
|
35
|
- Neutralizing agents
- Antisecretory agents
- Histamine H2 receptor
antagonists
- Prostaglandin analog
- Acid pump inhibitors
- Others (antibiotics, neutriceuticals)
|
|
36
|
|
|
37
|
- New oral-paste formulation of omeprazole developed specifically for
horses
- Well-studied, effective, and safe therapy for EGUS
- Approved for use in horses, March 1999
|
|
38
|
|
|
39
|
|
|
40
|
- Profound gastric acid suppression
- Prolonged duration of action
- Once-daily dosing
- Well studied in horses
- No reported treatment-related
- health problems in equine
trials
- Prevents ulcer recurrence
- Can maintain training program
- Approved for use in horses (GASTROGARD®)
|
|
41
|
- No IV formulation available in US
|
|
42
|
- Prevention of ulcers
- Non-perscription strength of
GastrogardÔ
- Sold through veterinarians
|
|
43
|
- Zantac® (ranitidine), Tagamet® (cimetidine)
- Competitive inhibition of the interaction of histamine with parietal
cell
- Dose-dependent inhibition of gastric acid secretion
|
|
44
|
- Availability
- Low cost (generic)
- Zantac® has been shown to significantly inhibit gastric acid secretion
in horses
- Must be administered 3X daily
|
|
45
|
- Amoxicillin, metronidazole, clarithromycin,
bismuth compounds, etc.
- Primarily used in humans with
Helicobacter pylori
- H. pylori has been associated with
the stomach of horses, but not EGUS
- Antimicrobials may be used in horses
with resistant EGUS
|
|
46
|
- Helicobacter specific DNA isolated from horse stomachs
- 2 horses with squamous erosions
- 1 horse with glandular erosions
- ACVIM Forum-Dallas (May 2002)
|
|
47
|
- NeighLox® (Kentucky Performance Products)
- Antacid and Coating Agents:
- Aluminum Phosphate, Calcium Carbonate
- Dihydroxy-Aluminium
Sodium Carbonate
- Labeled for prevention
of heartburn
- No studies in horses
to prove or disprove
- Probably does not
cause any harm
|
|
48
|
- G.U.T (Uckele Health & Nutrition)
- Gastric ulcer transnutrient for horses with ulcers
- Ingredients
- Gelatin
- Lactobacillus acidophilus, L. lactis
- Feed 15 grams (1 scoop) twice daily in horses with ulcers
- No studies proving efficacy
|
|
49
|
- TractGard (Foxden Equine)
- Equine GI rehydrator, antacid, digestaid, and electrolyte salt
- Ingredients (1 to 2 scoops daily)
- Calcium carbonate, Sodium sequiscarbonate, KCl, MgSO4,
distiller’s grain, yeast, and linseed meal
- No studies on efficacy
|
|
50
|
|
|
51
|
- EGUS is a major cause of illness
- 60-93% of performance horses have EGUS
- Impacts health, performance, economics
- Occurs when aggressive factors overpower gastric defenses
|
|
52
|
- Diagnosis requires endoscopy
- Presumptive diagnosis made based on clinical signs following complete
diagnostic evaluation
- Treatment: management and medical interventions
|
|
53
|
- Zantac®-healing 3X daily treatment
- Dietary supplements-not tested
- GastroGard® (omeprazole)
- Only FDA approved treatment
- Provides potent, long-lasting gastric acid suppression in horses
(once daily administration)
- 92% to 99% improvement in ulcer scores in trials and a wide safety
margin
- UlcerGardÔ Prevention of
Ulcers
|
|
54
|
- Part of EGUS (more commonly in foals)
- Similar pathogenesis
- Similar clinical signs
- Usually associated with bruxism, ptylism, and diarrhea (occurs most
often in foals)
- Delayed gastric emptying
- Associated with esophageal
- ulcers
|
|
55
|
- Diagnosis
- Clinical signs
- Duodenoscopy
- Radiology
- gastric emptying with barium
swallows (liquid meal=30 minutes)
- Necropsy
|
|
56
|
- Treatment
- Omeprazole (4 mg/kg, PO, Q24h, 28 days)
- Omeprazole (0.5 mg/kg, IV, Q24h)
- Ranitidine (6.6 mg/kg, PO, Q8h)
- Surgery-Gastrojejunostomy (foals only?)
|
|
57
|
- Uncommon in older horses
- Squamous cell carcinoma, most common
- Others: lymphosarcoma, adenosarcoma
- Arises from squamous mucosa and metastasizes to the abdominal cavity and
viscera and/or extends up the esophagus
- Clinical signs:
- Chronic weight loss
- Anemia
- Naso-gastric reflux
- Colic
|
|
58
|
- Diagnosis
- Clinical Signs
- Endoscopy (definitive)
- Abdominal ultrasound
- Necropsy
- Treatment: None
- Prognosis: Grave
|
|
59
|
- Infrequent cause of Colic in horses
- Dry feed material and decreased water intake
- May occur during winter when dry hay is fed and water intake is lower
- Diagnosed at surgery in horses with colic
- Endoscopic examination
- Treatment with dioctyl sodium succinate (DSS)
- 5% solution via NG tube in 4 to 6 L fluid
- Lavage at surgery, resolve in 24 – 48 hours
|